Epidemiology and problematic of invasive fungal infections;Épidémiologie et problématique des infections fongiques invasives

Journal de Mycologie Medicale

Volumn 12, Issue 3 SUPPL., 2002, Pages

  Thiebaut, A ^a  

^a EFFO Secretariat   (France)

Author keywords

Aspergillosis; Candidiasis; Diagnosis; Epidemiology; Risk factors; Systemic mycosis

Indexed keywords

ARTICLE; ASPERGILLOSIS; AUTOPSY; BLOOD CULTURE; CANDIDIASIS; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; FEVER; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; LUNG AGENESIS; LUNG INFILTRATE; MYCOSIS; NEUTROPENIA; PATIENT CARE; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTOR; THORAX RADIOGRAPHY;

EID: 0036742532     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ascioglu S, Rex JH, de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002;34:7-14.
2. Bow EJ, Loewen R, Cheang MS, Schacter B. Invasive fungal disease in adults undergoing remission induction therapy for acute myeloid leukemia. The pathogenic role of the antileukemic regimen. Clin Infect Dis 1995;21:361-9.
3. Bretagne S, Marmorat-Khuong A, Kuentz M, Latge JP, Bart-Delabesse E, Cordonnier C. Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients. J Infect 1997;35:7-15.
4. Buchheidt D, Baust C, Skladny H et al. Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results. Clin Infect Dis 2001;33:428-35.
5. Caillot D, Casasnovas O, Bernard A et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997;15:139-47.
6. Caillot D, Couaillier JF, Bernard A et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001;19:253-9.
7. Caillot D et al. Serial detection of Aspergillus antigenemia in neutropenic patients at risk of invasive pulmonary aspergillosis (IPA). Results of a prospective multicenter study. Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, 2000.
8. Denning DW, Marinus A, Cohen J et al. An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. J Infect 1998;37:173-80.
9. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998;26:781-805.
10. Einsele H, Quabeck K, Muller KD et al. Prediction of invasive pulmonary aspergillosis from colonization of lower respiratory tract before marrow transplantation. Lancet 1998;352:1443.
11. Ellis ME, Spence D, Bouchama A et al. Open lung provides a higher and more specific diagnostic yield compared to broncho-alveolar lavage in immunocompromised patients. Fungal Study Group. Scand J Infect Dis 1995;27:157-62.
12. Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukaemia. Ann intern Med 1984;100:345-51.
13. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996;33:23-32.
14. Guiot HF, Fibbe WE, van't Wout JW. Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. Clin Infect Dis 1994;18:525-32.
15. Hebart H, Loffler J, Reitze H et al. Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropenia. Br J Haematol 2000;111:635-40.
16. Huaringa AJ, Leyva FJ, Signes-Costa J et al. Bronchoalveolar lavage in the diagnosis of pulmonary complications of bone marrow transplant patients. Bone Marrow Transplant 2000;25:975-9.
17. Jantunen E, Piilonen A, Volin L et al. Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients. Bone Marrow Transplant 2000;25:867-71.
18. Jantunen E, Ruutu P, Niskanen L et al. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant 1997;19:801-8.
19. Kami M, Fukui T, Ogawa S et al. Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis 2001;33:1504-12.
20. Lortholary O, Ascioglu S, Moreau P et al. Invasive aspergillosis as an opportunistic infection in non allografted patients with multiple myeloma. Clin Infect Dis 2000;30:41-6.
21. Maertens J, Verhaegen J, Demuynck H et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for haematological patients at risk for invasive aspergillosis. J Clin Microbiol 1999;37:3223-8.
22. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a non invasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipient a prospective validation. Blood 2001;97:1604-10.
23. Nucci M, Colombo AL, Spector N, Velasco E, Martins CA, Pulcheri W. Breakthrough candidemia in neutropenic patients. Clin Infect Dis 1997:24;275-6.
24. O'Donnell MT et al. Prediction of systemic fungal infections in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients. J Clin Oncol 1994;4:827-34.
25. Paterson DL, Singh N. Invasive aspergillosis in transplant recipients. Medicine (Baltimore) 1999;78:123-38.
26. Piens MA, Lebeau B, Chapuis F et al. Latex Aspergillus antigen detection in invasive aspergillosis: calue in a multicenter prospective study. J Mycol Med 2001;11:61-6.
27. Prentice HG, Kibbler CC, Prentice AG. Towards a targeted, risk-based, antifungal strategy in neutropenic patients. Br J Haematol 2000;110:273-84.
28. Rex JH. Catheters and candidemia. Clin Infect Dis 1996;22:467-70.
29. Ribaud P, Chastang C, Latge JP et al. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. Clin Infect Dis 1999;28:322-30.
30. Riley LC, Hann IM, Wheatley K, Stevens RF. Treatment related death during induction and first remission of acute myeloid leukaemia in children treated on the tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10). Br J Haematol 1999;106:436-44.
31. Sayer HG, Longton G, Bowden R, Pepe M, Storb R. Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention. Blood 1994;4:1328-32.
32. Schwartz S, Behre G, Heinemann V et al. Aerosolized amphotericin B inhalations as prophylaxis of invasive Aspergillus infections during prolonged neutropenia: results of a prospective randomised multicenter trial. Blood 1999;11:3654-61.
33. Skladny H, Buchheidt D, Baust C et al. Specific detection of Aspergilllus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR. J Clin Microbiol 1999;37:3865-71.
34. Sulahian A, Boutboul F, Ribaud P, Leblanc T, Lacroix C, Derouin F. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 2001;91:311-8.
35. Uzun O, Ascioglu S, Anaissie EJ, Rex JH. Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia. Clin Infect Dis 2001;32:1713-7.
36. Verweij PE, Stynen D, Rijs AJ et al. Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients. J Clin Microbiol 1995;33:1912-4.
37. Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997;175:1459-66.
38. Young RC, Bennett JE, Vogel CL, Carbone PP, De Vita VT. Aspergillosis-the spectrum of the disease in 98 patients. Medicine (Baltimore) 1970;49:147-73.